Showing results (161-170 of 330) with videos related to
Sort By:
Pageof 33
Biochemical Pharmacology|May 5, 2024
HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancerRobert Jenke, Denys Oliinyk, Tamara Zenz, et al.Zeitschrift Fur Gastroenterologie|February 5, 2020
Current status of immunotherapy in gastrointestinal malignanciesSylvie Lorenzen, Florian Lordick, Sven Heiko Loosen, et al.Onkologie|October 8, 2010
Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in GermanyRalf-Dieter Hofheinz, Salah-Eddin Al-Batran, Karsten Ridwelski, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2007
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junctionHinrich A Wieder, Katja Ott, Florian Lordick, et al.International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancerClaus Rödel, Dirk Arnold, Matthias Hipp, et al.Oncotarget|September 13, 2014
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyMichaela Aichler, Martin Motschmann, Uta Jütting, et al.Journal of Cancer Research and Clinical Oncology|February 28, 2023
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumorsVivien Topf, Yuri Kheifetz, Severin Daum, et al.Oncology Research and Treatment|June 25, 2020
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer PatientsRuth Maria Schorling, Christian Pfrepper, Thomas Golombek, et al.Frontiers in Oncology|February 13, 2023
Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurabilityStefanie Solar, Johannes Wieditz, Florian Lordick, et al.BMC Cancer|July 21, 2016
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)Jens Hoeppner, Florian Lordick, Thomas Brunner, et al.Pageof 33